Purchase Order 75N91021P00121

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480.00 on March 30, 2020, with performance completion by March 31, 2021. Work is performed in Bethesda, Maryland. This firm fixed-price purchase order acquired molecular diagnostics products or services—specific scope details are not provided in the award documentation.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for one QIAsymphony SP System valued at $93,067.38 on August 19, 2020. The instrument supports the National Cancer Institute's Cancer Center for Research Laboratory of Pathology at its Germantown, Maryland location. The order carries firm fixed pricing and ultimate completion was scheduled for September 20, 2020. No small business set-aside applied.</p>

The National Cancer Institute awarded a $24,731 firm fixed-price purchase order to Qiagen, LLC on August 12, 2021, for laboratory equipment with an ultimate completion date of October 10, 2021. This contract was issued without a set-aside designation and was to be performed in Germantown, Maryland, where Qiagen's U.S. subsidiary is headquartered. The award represents an administrative de-obligation of unexpended and expiring Fiscal Year 2021 funding in preparation for the September 30, 2026...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,053 purchase order to Qiagen, LLC for service agreement work. Qiagen, a subsidiary of Qiagen N.V., will perform the services at its location in Bethesda, Maryland under the firm fixed price contract, which runs from September 1, 2023 through August 31, 2024. The award provides services to support the National Cancer Institute's research efforts as it works to prevent and cure cancer....

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC valued at $6,021.00 on August 22, 2017 for service agreements supporting QIAxcel and QIACube instruments. Performance is at Bethesda, Maryland. The purchase order provides maintenance and support services to ensure continued availability of these sample preparation and analysis instruments. Performance concludes on September 20, 2018.</p>

<p>The National Cancer Institute issued a $17,792.10 delivery order to Illumina, Inc. on January 13, 2020, for reagents and consumables.</p> <p>Place of performance is Bethesda, MD 20892. Ultimate completion date is February 12, 2020. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,053 purchase order to Qiagen, LLC for maintenance agreement services. Qiagen, LLC is a division of Qiagen N.V., a global life sciences company, and will perform the services at its location in Bethesda, Maryland between August 2023 and August 2024 under firm fixed pricing. The award provides support for an existing Qiagen product or solution under a one-year period of performance...

<p>The National Cancer Institute issued a purchase order to Nanostring Technologies, Inc. valued at $24,750.00 on January 9, 2020 for laboratory testing and service. Performance occurs in Bethesda, Maryland with an ultimate completion date of February 29, 2020. The order covers specialized laboratory equipment, reagents, assays, or testing services in support of genomic, molecular, and cellular analysis for biomedical research. No set-aside category applies.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $15,500.00 with an award date of March 13, 2020 and ultimate completion date of March 12, 2021. Performance occurs in Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. The specific commodities or services procured are not detailed in the source.</p>